Theseus Pharmaceuticals, Inc. (THRX) Balance Sheet Annual - Discounting Cash Flows
Theseus Pharmaceuticals, Inc.
THRX (NASDAQ)

* (except for per share items) of USD
Period Ending: 2022
12-31
2021
12-31
2020
12-31
2019
12-31
Report Filing: 2023-03-09 2022-03-10 2020-12-31 2019-12-31
Total Current Assets 198 248 8.57 1.38
Cash and Short Term Investments 198 244.7 8.46 1.32
Cash & Equivalents 94.61 244.7 8.46 1.32
Short Term Investments 103.4 0 0 0
Receivables 0 0 0 0
Inventory 0 0 0 0
Other Current Assets 0 3.31 0.113 0.064
Total Assets 222.4 250.9 8.61 1.43
Total Non-Current Assets 24.47 2.96 0.044 0.046
Property, Plant and Equipment 4.75 0.011 0.001 0.003
Goodwill and Intangible Assets 0 0 0 0
Goodwill 0 0 0 0
Intangible Assets 0 0 0 0
Long Term Investments 13.82 0.379 0 0
Deferred Tax Assets 0 0 0 0
Other Long Term Assets 5.9 2.57 0.043 0.043
Total Current Liabilities 11.13 3.68 1.59 0.615
Accounts Payable 4.97 1 1.13 0.285
Notes Payable/Short Term Debt 0.743 0 0 0
Tax Payables 0 0 0 0
Deferred Revenue 0 0 0 0
Other Current Liabilities 5.41 2.68 0.463 0.33
Total Liabilities 14.83 4.5 42.88 10.83
Total Non-Current Liabilities 3.7 0.815 41.29 10.22
Total Long Term Debt 3.24 0 0 0
Deferred Tax Liabilities Non-Current 0 0 0 0
Deferred Revenue Non-Current 0 0 0 0
Capital Lease Obligations 0 0 0 0
Other Long Term Liabilities 0.466 0.815 41.29 10.22
Total Equity 207.6 246.4 -34.27 -9.41
Non-Controlling Interest 0 0 0 0
Total Stockholders' Equity 207.6 246.4 -34.27 -9.41
Retained Earnings -112.2 -61.58 -34.27 -10.22
Accumulated Other Earnings -0.386 -250.9 0 0.813
Common Stock 0.004 0.004 0 0
Preferred Stock 0 250.9 41.29 6.86
Additional Paid in Capital 320.2 308 -41.29 -6.04
Total Liabilities & Total Equity 222.4 250.9 8.61 1.43
Total Liabilities & Shareholders' Equity 222.4 250.9 8.61 1.43
Total Investments 117.2 0.379 0 0
Total Debt 3.98 0 0 0
Net Debt -90.63 -244.7 -8.46 -1.32
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us